Find clinical trials for Lymphoma in Charlotte, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Charlotte, NC, USA:
This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...
Phase 2
Charlotte, North Carolina, United States and 7 other locations
The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma...
Phase 2
Charlotte, North Carolina, United States and 3 other locations
017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....
Phase 1
Charlotte, North Carolina, United States and 13 other locations
dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 104 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Charlotte, North Carolina, United States and 215 other locations
with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:To improve the event-free surv...
Phase 2, Phase 3
Charlotte, North Carolina, United States and 7 other locations
with various types of blood cancers:relapsed or refractory (R/R) lymphomamultiple myelomanewly diagnosed acute myeloid leukemia (AML).This t...
Phase 1
Charlotte, North Carolina, United States and 61 other locations
T cells, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma.The study will consist of 2 parts: dose-escalation (Part A) and...
Phase 1
Charlotte, North Carolina, United States and 13 other locations
This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...
Phase 3
Charlotte, North Carolina, United States and 119 other locations
pharmacokinetic profile of GRC54276 alone and in combination with pembrolizumab or atezolizumab in participants with advanced solid tumors and lymphomas...
Phase 1
Huntersville, North Carolina, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal